Search Results - "Fosmark, S."

Prognostic value of O‐6‐methylguanine–DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis by Dahlrot, R. H., Dowsett, J., Fosmark, S., Malmström, A., Henriksson, R., Boldt, H., Stricker, K., Sørensen, M. D., Poulsen, H. S., Lysiak, M., Söderkvist, P., Rosell, J., Hansen, S., Kristensen, B. W.

“…Aims It is important to predict response to treatment with temozolomide (TMZ) in glioblastoma (GBM) patients. Both MGMT protein expression and MGMT promoter…”
Get full text

Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study by Skrivarhaug, T, Fosmark, D. S, Stene, L. C, Bangstad, H.-J, Sandvik, L, Hanssen, K. F, Joner, G

“…Aims/hypothesis We estimated cumulative incidence of proliferative diabetic retinopathy (PDR) and risk factors for developing diabetic retinopathy (DR) in…”
Get full text

Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone by Fosmark, Dag S., Berg, Jens P., Jensen, Aase‐Brith, Sandvik, Leiv, Agardh, Elisabet, Agardh, Carl‐David, Hanssen, Kristian F.

“… Purpose:  We aimed to investigate associations between serum levels of the advanced glycation endproduct methylglyoxal‐derived hydroimidazolone (MG‐H1) and…”
Get full text

Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case‐control study by Fosmark, Dag S., Bragadóttir, Ragnheid̄ur, Stene‐Johansen, Ingar, Berg, Jens P., Berg, Tore J., Lund, Terje, Sandvik, Leiv, Hanssen, Kristian F.

“… Purpose:  As advanced glycation endproducts (AGEs) and the vitreous body are both considered to be involved in the development of diabetic retinopathy and…”
Get full text

Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus by Fosmark, Dag Sigurd, Torjesen, Peter A., Kilhovd, Bente K., Berg, Tore J., Sandvik, Leiv, Hanssen, Kristian F., Agardh, Carl-David, Agardh, Elisabet

“…Advanced glycation end products (AGEs) are thought to play a major pathogenic role in diabetic retinopathy. The most important AGE is unknown, but as increased…”
Get full text